Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Jin Medical International (ZJYL) Accounts Payables (2022 - 2025)

Historic Accounts Payables for Jin Medical International (ZJYL) over the last 4 years, with Q3 2025 value amounting to $3.3 million.

  • Jin Medical International's Accounts Payables rose 810.97% to $3.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.3 million, marking a year-over-year increase of 810.97%. This contributed to the annual value of $3.3 million for FY2025, which is 810.97% up from last year.
  • Jin Medical International's Accounts Payables amounted to $3.3 million in Q3 2025, which was up 810.97% from $3.1 million recorded in Q1 2025.
  • In the past 5 years, Jin Medical International's Accounts Payables ranged from a high of $4.1 million in Q3 2022 and a low of -$278216.0 during Q1 2024
  • For the 4-year period, Jin Medical International's Accounts Payables averaged around $2.4 million, with its median value being $3.1 million (2025).
  • Its Accounts Payables has fluctuated over the past 5 years, first plummeted by 17981.43% in 2024, then surged by 119844.83% in 2025.
  • Over the past 4 years, Jin Medical International's Accounts Payables (Quarter) stood at $4.1 million in 2022, then decreased by 17.56% to $3.4 million in 2023, then fell by 11.17% to $3.0 million in 2024, then rose by 8.11% to $3.3 million in 2025.
  • Its Accounts Payables stands at $3.3 million for Q3 2025, versus $3.1 million for Q1 2025 and $3.0 million for Q3 2024.